Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

Petar M Seferović¹, Hiroyuki Tsutsui², Dennis M McNamara³, Arsen D Ristić^{4

5}, Cristina Basso⁶, Biykem Bozkurt⁷, Leslie T Cooper Jr⁸, Gerasimos Filippatos⁹, Tomomi Ide², Takayuki Inomata¹⁰, Karin Klingel¹¹, Aleš Linhart¹², Alexander R Lyon¹³, Mandeep R Mehra¹⁴, Marija Polovina^{4

5}, Ivan Milinković^{4

5}, Kazufumi Nakamura¹⁵, Stefan D Anker¹⁶, Ivana Veljić⁴, Tomohito Ohtani¹⁷, Takahiro Okumura¹⁸, Thomas Thum^{19

20}, Carsten Tschöpe²¹, Giuseppe Rosano^{22

23}, Andrew J S Coats^{24

25}, Randall C Starling²⁶

Affiliations

¹ Serbian Academy of Sciences and Arts, Belgrade, Serbia.
² Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
³ Heart and Vascur Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁴ Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
⁵ Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
⁶ Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
⁷ Winters Center for Heart Failure, Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
⁸ Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
⁹ Attikon University Hospital, Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
¹⁰ Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
¹¹ Cardiopathology, Institute for Pathology, University Hospital, Tuebingen, Germany.
¹² Department of Cardiovascular Medicine, Charles University, Prague, Czech Republic.
¹³ National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.
¹⁴ Heart and Vascular Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
¹⁵ Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
¹⁶ Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin, Berlin, Germany.
¹⁷ Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
¹⁸ Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹⁹ Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
²⁰ Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
²¹ Berlin Institute of Health (BIH) and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Department of Cardiology, Campus Virchow Klinikum, Charite University, Berlin, Germany.
²² Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy.
²³ Cardiology Clinical Academic Group, St George's Hospitals NHS Trust, London, UK.
²⁴ Monash University, Melbourne, Australia.
²⁵ University of Warwick, Coventry, UK.
²⁶ Cleveland Clinic, Cleveland, OH, USA.

PMID: 34010472
DOI: 10.1002/ejhf.2190

Free article

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

Petar M Seferović et al. Eur J Heart Fail. 2021 Jun.

Free article

. 2021 Jun;23(6):854-871.

doi: 10.1002/ejhf.2190. Epub 2021 May 19.

Authors

Affiliations

¹ Serbian Academy of Sciences and Arts, Belgrade, Serbia.
² Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
³ Heart and Vascur Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁴ Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
⁵ Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
⁶ Cardiovascular Pathology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Padua, Italy.
⁷ Winters Center for Heart Failure, Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
⁸ Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
⁹ Attikon University Hospital, Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
¹⁰ Department of Cardiovascular Medicine, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
¹¹ Cardiopathology, Institute for Pathology, University Hospital, Tuebingen, Germany.
¹² Department of Cardiovascular Medicine, Charles University, Prague, Czech Republic.
¹³ National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK.
¹⁴ Heart and Vascular Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
¹⁵ Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
¹⁶ Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin, Berlin, Germany.
¹⁷ Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
¹⁸ Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹⁹ Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
²⁰ Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
²¹ Berlin Institute of Health (BIH) and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Department of Cardiology, Campus Virchow Klinikum, Charite University, Berlin, Germany.
²² Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy.
²³ Cardiology Clinical Academic Group, St George's Hospitals NHS Trust, London, UK.
²⁴ Monash University, Melbourne, Australia.
²⁵ University of Warwick, Coventry, UK.
²⁶ Cleveland Clinic, Cleveland, OH, USA.

PMID: 34010472
DOI: 10.1002/ejhf.2190

Erratum in

Corrigendum to 'Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy' [Eur J Heart Fail 2021;23:854-871].
[No authors listed] [No authors listed] Eur J Heart Fail. 2022 Apr;24(4):732. doi: 10.1002/ejhf.2474. Epub 2022 Mar 17. Eur J Heart Fail. 2022. PMID: 35301785 No abstract available.

Abstract

Endomyocardial biopsy (EMB) is an invasive procedure, globally most often used for the monitoring of heart transplant (HTx) rejection. In addition, EMB can have an important complementary role to the clinical assessment in establishing the diagnosis of diverse cardiac disorders, including myocarditis, cardiomyopathies, drug-related cardiotoxicity, amyloidosis, other infiltrative and storage disorders, and cardiac tumours. Improvements in EMB equipment and the development of new techniques for the analysis of EMB samples have significantly improved diagnostic precision of EMB. The present document is the result of the Trilateral Cooperation Project between the Heart Failure Association of the European Society of Cardiology, the Heart Failure Society of America, and the Japanese Heart Failure Society. It represents an expert consensus aiming to provide a comprehensive, up-to-date perspective on EMB, with a focus on the following main issues: (i) an overview of the practical approach to EMB, (ii) an update on indications for EMB, (iii) a revised plan for HTx rejection surveillance, (iv) the impact of multimodality imaging on EMB, and (v) the current clinical practice in the worldwide use of EMB.

Keywords: Amyloidosis; Cardiac tumours; Cardiomyopathy; Cardiotoxicity; Endomyocardial biopsy; Heart failure; Heart transplantation; Myocarditis; Sarcoidosis.

PubMed Disclaimer

Comment in

Endomyocardial biopsy in the hands of the electrophysiologist: the 'one-stop shop' for arrhythmic non-ischaemic cardiomyopathy. Letter regarding the article 'Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy'.
Compagnucci P, Dello Russo A, Casella M. Compagnucci P, et al. Eur J Heart Fail. 2021 Nov;23(11):1983. doi: 10.1002/ejhf.2340. Epub 2021 Sep 15. Eur J Heart Fail. 2021. PMID: 34506077 Free PMC article. No abstract available.
Reply to "Endomyocardial biopsy in the hands of the electrophysiologist: the 'one-stop shop' for arrhythmic non-ischaemic cardiomyopathy".
Seferović PM. Seferović PM. Eur J Heart Fail. 2021 Nov;23(11):1984. doi: 10.1002/ejhf.2349. Epub 2021 Sep 26. Eur J Heart Fail. 2021. PMID: 34529318 No abstract available.

References

1. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 2007;28:3076-3093.
1. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, d'Amati G, Edwards WD, Fallon JT, Fishbein MC, Gallagher PJ, Halushka MK, McManus B, Pucci A, Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C, Thiene G, van der Wal AC, Winters GL. 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 2012;21:245-274.
1. Konno S, Sakakibara S. Endo-myocardial biopsy. Dis Chest 1963;44:345-350.
1. Sakakibara S, Konno S. Endomyocardial biopsy. Jpn Heart J 1962;3:537-543.
1. Sekiguchi M, Konno S. Histopathological differentiation employing endomyocardial biopsy in the clinical assessment of primary myocardial disease. Jpn Heart J 1969;10:30-46.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

Affiliations

Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy

Authors

Affiliations

Erratum in

Abstract

Comment in

References

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources